Management of Low Ferritin in a Menstruating 19-Year-Old
Start oral iron supplementation immediately—a ferritin of 21.6 µg/L indicates depleted iron stores that warrant treatment, even though frank anemia is not yet present. 1
Why Treatment Is Indicated
Ferritin < 45 µg/L provides optimal sensitivity and specificity (≈92%) for iron deficiency and should trigger intervention, particularly in menstruating women who are at high risk for progressive depletion. 1
Although the classic threshold of < 15 µg/L is 99% specific for absolute deficiency, ferritin levels between 15–45 µg/L indicate iron deficiency is highly likely and full evaluation plus treatment are warranted. 1
In menstruating women specifically, ferritin < 50 µg/L has been shown to cause unexplained fatigue and responds well to iron supplementation, with a 47.7% reduction in fatigue scores versus 28.8% with placebo. 2
The normal TIBC in this case is reassuring—profoundly low transferrin saturation with elevated TIBC is the classic pattern of absolute iron deficiency, but normal TIBC with low ferritin still indicates depleted stores requiring repletion. 1
Recommended Treatment Regimen
Prescribe oral ferrous sulfate 80 mg elemental iron daily (or equivalent ferrous fumarate/gluconate) as first-line therapy; no single oral preparation has demonstrated superiority. 1
Iron absorption is optimal on an empty stomach, but if gastrointestinal side effects occur, taking with meals improves tolerability; co-administration with approximately 500 mg vitamin C enhances absorption. 1
Low-dose supplementation (18–20 mg daily) is effective in iron-depleted non-anemic menstruating women and may be better tolerated than higher doses, though repletion takes longer. 3
Continue treatment for at least 3–6 months to replenish stores; studies show significant ferritin increases from mean 24 to 41 µg/L after just 1 month, but levels can fall again after discontinuation. 4
Monitoring Response
Recheck ferritin and hemoglobin at 6 weeks to assess treatment efficiency; a rise in hemoglobin ≥10 g/L within 2 weeks strongly confirms iron deficiency. 1, 2
Target ferritin > 50 µg/L to ensure adequate stores and symptom resolution in menstruating women. 2
If no response occurs after 6 weeks of adequate oral therapy, consider malabsorption (celiac disease should be tested), non-compliance, or ongoing blood loss exceeding replacement. 1
Additional Evaluation Needed
Assess menstrual blood loss through detailed history—heavy menstrual bleeding is the most common cause in this demographic and may require gynecologic management. 1, 5
Screen for celiac disease with serology, as it is identified in approximately 3–5% of iron-deficiency cases and impairs intestinal iron absorption. 1
Review dietary iron intake and refer to nutrition counseling to address possible insufficient intake, particularly in vegetarian/vegan diets. 1
Obtain urinalysis to exclude occult urinary blood loss as a contributing source. 1
When to Consider GI Investigation
In this premenopausal woman with menstruation as an obvious source, GI investigation is warranted only if: (1) GI-related symptoms are present, (2) family history of GI pathology exists, or (3) anemia persists despite adequate iron replacement and menstrual management. 1
Do not pursue urgent endoscopy in young menstruating women with isolated low ferritin and normal hemoglobin unless the above red flags are present. 1
Critical Pitfalls to Avoid
Do not wait for anemia to develop before treating—iron stores are already depleted at ferritin 21.6 µg/L, and symptoms (particularly fatigue) respond to repletion even in the absence of anemia. 2
Do not accept ferritin levels that fall after treatment cessation—menstruating women often require ongoing maintenance supplementation or periodic courses to prevent recurrent depletion. 4
Do not overlook heavy menstrual bleeding as the primary driver; if present, coordinate with gynecology for hormonal management or other interventions to reduce menstrual blood loss. 5